Understanding erectile dysfunction medication preference studies Journal Article


Author: Mulhall, J. P.
Article Title: Understanding erectile dysfunction medication preference studies
Abstract: Purpose of review: The existence of three phosphodiesterase 5 inhibitors has resulted in an increase in the marketing of the drugs. This has led to a shift in focus from scientifically rigorous endpoints such as efficacy and adverse event profiles to patient preference. Recent findings: Although no consensus currently exists as to the correct methodology for preference studies, some basic guidelines should be adhered to, including: (1) the double-blinding of drug administration; (2) non-biased drug administration instructions; (3) an adequately conducted crossover study; (4) comparison of equivalent doses; (5) standardized preference assessment; (6) declaration of patient demographics; and (7) rigorous statistical analysis. These factors are discussed in the light of the three published preference studies. Summary: In the final analysis, it is unclear to this author how preference studies impact upon clinician decision-making when confronted by a patient with erectile dysfunction.
Keywords: patient satisfaction; review; drug efficacy; side effect; physician's practice patterns; medical decision making; practice guideline; disease severity; statistical analysis; data interpretation, statistical; comorbidity; erectile dysfunction; phosphodiesterase v inhibitor; sildenafil; tadalafil; vardenafil; phosphodiesterase inhibitors; impotence; clinical trials; penis erection; drug choice; cross-over studies; drug marketing; pharmacotherapy; hardness; preference; humans; human; male; priority journal; drug trials; taste preference
Journal Title: Current Opinion in Urology
Volume: 14
Issue: 6
ISSN: 0963-0643
Publisher: Lippincott Williams & Wilkins  
Date Published: 2004-11-01
Start Page: 367
End Page: 373
Language: English
DOI: 10.1097/00042307-200411000-00013
PROVIDER: scopus
PUBMED: 15626881
DOI/URL:
Notes: Curr. Opin. Urol. -- Cited By (since 1996):25 -- Export Date: 16 June 2014 -- CODEN: CUOUE -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. John P Mulhall
    601 Mulhall